SWOG clinical trial number
CTSU/R1112

Randomized Phase III Study of Sorafenib Versus Stereotactic Body Radiation Therapy Followed by Sorafenib in Hepatocellular Carcinoma

Open
Phase
III
Abbreviated Title
R PhIII Sorafenib vs SBRT followed by Sorafenib in Hepatocellular Carcinoma
Status Notes
This protocol is open to accrual effective 6/15/16.
Activated
06/15/2016
Participants
ALL NATIONAL CLINICAL TRIALS NETWORK MEMBERS

Research committees

Gastrointestinal Cancer
Symptom Control and Quality of Life

Treatment

BAY 43-9006 RT

Other Clinical Trials

SWOG Clinical Trial Number
S1714

A Prospective Observational Cohort Study to Develop a Predictive Model of Taxane-Induced Peripheral Neuropathy in Cancer Patients

Research Committee(s)
Symptom Control and Quality of Life
Breast Cancer
Lung Cancer
Early Therapeutics & Rare Cancers
Activated
03/01/2019
Accrual
7%
Open
Phase
SWOG Clinical Trial Number
S1600

A Randomized Phase III Double-Blind Clinical Trial Evaluating the Effect of Immune-Enhancing Nutrition on Radical Cystectomy Outcomes

Research Committee(s)
Symptom Control and Quality of Life
Genitourinary Cancer
Activated
02/21/2019
Accrual
8%
Open
Phase
III
SWOG Clinical Trial Number
S1614

Randomized Trial of Prophylactic Antiviral Therapy in Patients with Current or Past Hepatitis B Virus (HBV) Infection Receiving Cytotoxic Therapy for Solid Tumors

Research Committee(s)
Symptom Control and Quality of Life
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Lung Cancer
Melanoma
Activated
02/21/2019
Accrual
0%
Open